Frequencies of VKORC1-1639G>A and rs397509427 in Patients on Warfarin and Healthy Syrian Subjects
Background. Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene encodes a key enzyme with multiple cellular activities, namely, the reduction of vitamin K to its active form. VKORC1-1639G>A (rs9923231) is a common single nucleotide polymorphism with a crucial impact on warfarin dosing and...
Main Authors: | Yara Altawil, Lama A. Youssef |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2023-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2023/8898922 |
Similar Items
-
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report
by: Weam Aldiban, et al.
Published: (2022-10-01) -
VKORC1 gene polymorphism (-1639G>A) in warfarin therapy patients of Pakistani population
by: Muhammad Bilal Ghafoor, et al.
Published: (2022-02-01) -
Value of VKORC1 (−1639G>A) rs9923231 genotyping in predicting warfarin dose: A replication study in South Indian population
by: S. Harikrishnan, et al.
Published: (2018-12-01) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011) -
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010)